Jiangsu Bioperfectus Technologies Co., Ltd. (688399.SH) has repurchased a total of 3.02% of its shares, costing 136 million yuan.
Shuo Shi Biology (688399.SH) announced that as of September 23, 2024, the company has completed centralized trading...
Jiangsu Bioperfectus Technologies Co., Ltd. (688399.SH) announced that as of September 23, 2024, the company has repurchased a total of 1,772,000 shares through centralized bidding trading, accounting for 3.02% of the company's total share capital. The highest purchase price was 80.55 yuan per share, the lowest price was 69.70 yuan per share, and the total amount paid was 136 million yuan (excluding stamp duty, transaction commission, and other transaction fees).
Related Articles
Anhui Anke Biotechnology (300009.SZ) and its subsidiary will exclusively distribute Recombinant human follicle-stimulating hormone-CTP fusion protein injection.
WuXi AppTec (02359) spent 20.0073 million yuan to repurchase 285,700 shares of A shares on July 9th.
COFCO JOYCOME (01610) June output of hogs was 427,000 heads.
Anhui Anke Biotechnology (300009.SZ) and its subsidiary will exclusively distribute Recombinant human follicle-stimulating hormone-CTP fusion protein injection.
WuXi AppTec (02359) spent 20.0073 million yuan to repurchase 285,700 shares of A shares on July 9th.
COFCO JOYCOME (01610) June output of hogs was 427,000 heads.
RECOMMEND
Li Ning Faces Sharp Decline in Market Value Amid Strategic Uncertainty and Brand Challenges
08/07/2025
First Batch of Copper Arrives in Hong Kong Warehouses, to Join LME Global Storage Network
08/07/2025
NDRC and Three Departments Jointly Issue Notice to Advance Grid Construction and High-Power Charging Infrastructure Development
08/07/2025
